Literature DB >> 7641016

Treatment trends for ductal carcinoma in situ of the breast.

D P Winchester1, H R Menck, R T Osteen, W Kraybill.   

Abstract

BACKGROUND: As a result of clinical trial publications, breast conservation treatment has been increasingly used for invasive breast cancer. The patterns of care for ductal carcinoma in situ (DCIS) were analyzed for the years 1985, 1986, 1988, 1990, and 1991 to determine whether the same treatment principles had been applied to patients with non-invasive disease.
METHODS: Data submitted on 20,556 patients with DCIS during the 5 study years were analyzed with regard to basic demographics and treatment trends.
RESULTS: Breast-conserving surgery for DCIS increased from 20.9% in 1985 to 35.4% in 1991. Modified radical mastectomy remained constant at 42%. Axillary node surgery increased from 52% in 1985 to 58.5% in 1991. The use of radiation therapy for patients with partial mastectomy and no lymph node dissection ranges from 24.2% in 1990 to 37.7% in 1985, with 31.1% receiving radiation therapy in 1991. Patients undergoing lymph node dissection with partial mastectomy were more than twice as likely to receive postoperative radiation therapy than were patients without lymph node dissection.
CONCLUSIONS: Modified radical mastectomy remains the most common surgical procedure, despite the eligibility of many women for breast conservation treatment. As of 1991 the majority of women were still undergoing axillary lymph node surgery despite a node positivity rate of approximately 1%. Radiation therapy is significantly underused in patients with partial mastectomy, especially when no nodes were removed. Clinical trial results and professional education for DCIS treatment should change these trends.

Entities:  

Mesh:

Year:  1995        PMID: 7641016     DOI: 10.1007/bf02307025

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Trends in the surgical treatment of ductal carcinoma in situ of the breast.

Authors:  E A Coleman; L G Kessler; L M Wun; E J Feuer
Journal:  Am J Surg       Date:  1992-07       Impact factor: 2.565

2.  Regional differences in surgical management of breast cancer.

Authors:  R T Osteen; G D Steele; H R Menck; D P Winchester
Journal:  CA Cancer J Clin       Date:  1992 Jan-Feb       Impact factor: 508.702

3.  The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons.

Authors:  R E Wilson; W L Donegan; C Mettlin; N Natarajan; C R Smart; G P Murphy
Journal:  Surg Gynecol Obstet       Date:  1984-10

4.  Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?

Authors:  M J Silverstein; R J Rosser; E D Gierson; J R Waisman; P Gamagami; R S Hoffman; A G Fingerhut; B S Lewinsky; W Colburn; N Handel
Journal:  Cancer       Date:  1987-05-15       Impact factor: 6.860

5.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.

Authors:  M D Lagios; F R Margolin; P R Westdahl; M R Rose
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

6.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.

Authors:  B Fisher; J Costantino; C Redmond; E Fisher; R Margolese; N Dimitrov; N Wolmark; D L Wickerham; M Deutsch; L Ore
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

7.  Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results.

Authors:  U Veronesi; A Banfi; M Del Vecchio; R Saccozzi; C Clemente; M Greco; A Luini; E Marubini; G Muscolino; F Rilke
Journal:  Eur J Cancer Clin Oncol       Date:  1986-09

8.  Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.

Authors:  G F Schwartz; G C Finkel; J C Garcia; A S Patchefsky
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

9.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.

Authors:  B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch
Journal:  N Engl J Med       Date:  1989-03-30       Impact factor: 91.245

10.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.

Authors:  D Sarrazin; M G Lê; R Arriagada; G Contesso; F Fontaine; M Spielmann; F Rochard; T Le Chevalier; J Lacour
Journal:  Radiother Oncol       Date:  1989-03       Impact factor: 6.280

View more
  5 in total

1.  Is mastectomy overused? A call for an expanded research agenda.

Authors:  Paula V Lantz; Judith K Zemencuk; Steven J Katz
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

2.  Ductal Carcinoma in Situ: Clinical Perspective.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2010-08-02       Impact factor: 2.860

3.  Receipt of delayed breast reconstruction after mastectomy: do women revisit the decision?

Authors:  Amy K Alderman; Sarah T Hawley; Monica Morrow; Barbara Salem; Ann Hamilton; John J Graff; Steven Katz
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

Review 4.  Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Authors:  Hilary M Shapiro-Wright; Thomas B Julian
Journal:  J Natl Cancer Inst Monogr       Date:  2010

5.  Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.

Authors:  Serena Bertozzi; Carla Cedolini; Ambrogio P Londero; Barbara Baita; Francesco Giacomuzzi; Decio Capobianco; Marta Tortelli; Alessandro Uzzau; Laura Mariuzzi; Andrea Risaliti
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.